Log in

LON:GSK - GlaxoSmithKline Share Price, Forecast & News

GBX 1,729.40
+22.60 (+1.32 %)
(As of 12/8/2019 04:00 PM ET)
Today's Range
1,704.80
Now: GBX 1,729.40
1,731.20
50-Day Range
1,639.80
MA: GBX 1,718.22
1,782
52-Week Range
1,421.80
Now: GBX 1,729.40
1,796.40
Volume6.55 million shs
Average Volume9.12 million shs
Market Capitalization£86.29 billion
P/E Ratio18.94
Dividend Yield5.39%
BetaN/A
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. Read More…

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-80475000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£33.05 billion
Cash FlowGBX 89.23 per share
Book ValueGBX 237.70 per share

Profitability

Miscellaneous

Employees95,490
Outstanding Shares4,989,320,192
Market Cap£86.29 billion
Next Earnings Date2/5/2020 (Estimated)
OptionableOptionable

Receive GSK News and Ratings via Email

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.


GlaxoSmithKline (LON:GSK) Frequently Asked Questions

What is GlaxoSmithKline's stock symbol?

GlaxoSmithKline trades on the London Stock Exchange (LON) under the ticker symbol "GSK."

How often does GlaxoSmithKline pay dividends? What is the dividend yield for GlaxoSmithKline?

GlaxoSmithKline announced a dividend on Wednesday, October 30th. Stockholders of record on Thursday, November 14th will be given a dividend of GBX 19 per share on Thursday, January 9th. This represents a dividend yield of 1.07%. The ex-dividend date of this dividend is Thursday, November 14th. The official announcement can be accessed at this link. View GlaxoSmithKline's Dividend History.

How were GlaxoSmithKline's earnings last quarter?

GlaxoSmithKline plc (LON:GSK) posted its earnings results on Wednesday, April, 25th. The company reported $24.60 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $24.30 by $0.30. View GlaxoSmithKline's Earnings History.

When is GlaxoSmithKline's next earnings date?

GlaxoSmithKline is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for GlaxoSmithKline.

What price target have analysts set for GSK?

16 brokerages have issued twelve-month price targets for GlaxoSmithKline's stock. Their forecasts range from GBX 1,520 to GBX 2,110. On average, they anticipate GlaxoSmithKline's stock price to reach GBX 1,794.64 in the next twelve months. This suggests a possible upside of 3.8% from the stock's current price. View Analyst Price Targets for GlaxoSmithKline.

What is the consensus analysts' recommendation for GlaxoSmithKline?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last year. There are currently 1 sell rating, 10 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for GlaxoSmithKline.

Has GlaxoSmithKline been receiving favorable news coverage?

News headlines about GSK stock have trended negative on Sunday, InfoTrie Sentiment reports. The research group scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. GlaxoSmithKline earned a news impact score of -2.1 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for GlaxoSmithKline.

Who are some of GlaxoSmithKline's key competitors?

What other stocks do shareholders of GlaxoSmithKline own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GlaxoSmithKline investors own include AstraZeneca (AZN), General Electric (GE), Intel (INTC), AT&T (T), Vodafone Group (VOD), Bank of America (BAC), Allergan (AGN), Pfizer (PFE), Royal Dutch Shell (RDSB) and BP (BP).

Who are GlaxoSmithKline's key executives?

GlaxoSmithKline's management team includes the folowing people:
  • Ms. Emma N. Walmsley, CEO & Director (Age 49)
  • Dr. Hal V. Barron, Chief Scientific Officer, Pres of R&D and Director (Age 56)
  • Mr. Simon P. Dingemans, Exec. Director (Age 55)
  • Mr. Jack Bailey, Pres of US Pharmaceuticals
  • Mr. Iain James Mackay, CFO & Exec. Director (Age 57)

How do I buy shares of GlaxoSmithKline?

Shares of GSK and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is GlaxoSmithKline's stock price today?

One share of GSK stock can currently be purchased for approximately GBX 1,729.40.

How big of a company is GlaxoSmithKline?

GlaxoSmithKline has a market capitalization of £86.29 billion and generates £33.05 billion in revenue each year. GlaxoSmithKline employs 95,490 workers across the globe.View Additional Information About GlaxoSmithKline.

What is GlaxoSmithKline's official website?

The official website for GlaxoSmithKline is http://www.gsk.com/.

How can I contact GlaxoSmithKline?

GlaxoSmithKline's mailing address is 980 Great West Road, BRENTFORD, TW8 9GS, United Kingdom. The company can be reached via phone at +44-20-80475000.


MarketBeat Community Rating for GlaxoSmithKline (LON GSK)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  939 (Vote Outperform)
Underperform Votes:  1,521 (Vote Underperform)
Total Votes:  2,460
MarketBeat's community ratings are surveys of what our community members think about GlaxoSmithKline and other stocks. Vote "Outperform" if you believe GSK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GSK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/8/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel